Abstract:Abstract Pediatric glioblastoma multiforme (pGBM) is a highly aggressive brain tumor with poor prognosis. Resistance to ionizing radiation, which is one of the major therapeutic regimes, is believed to play a critical role in tumor recurrence and ultimate treatment failure. However, little is known about the cellular and molecular mechanisms of radioresistance in pGBM, particularly the in vivo responses of tumor cells toward clinically relevant fractionated radiotherapy. To gain a better understanding of the radioresistance mechanisms, we administered fractionated radiation (2Gy per day × 5 times) to SCID mice bearing pre-established orthotopic xenograft tumors derived from two independent fresh patient tumors. Examination of the xenograft tumors immediately at the end of radiation treatment showed that the fractionated radiotherapy significantly increased the abundance of CD133+ tumor cells, and drove quiescent G0 phase cells (both CD133+ and CD133-) into G1 phase in both models. Immunohistochemical examination of key regulators of stem cell self-renewal revealed elevation of BMI-1 and SOX2 gene expression in vivo in the xenograft tumors. Additionally, we found that radiotherapy promoted mesenchymal transition, as the intensity and distribution of fibronectin, a mesenchymal marker, was remarkably enhanced. Further analysis of the recurrent xenograft tumors ∼ 5 weeks post-fractionated radiation showed that the increased CD133+ fraction, the elevated expressions of BMI-1 and SOX2 as well as fibronection were maintained. In conclusion, our data demonstrated, for the first time, that failure of radiotherapy is mediated by activated pathways related to self-renewal of cancer stem cells and mesenchymal transition. Since this study was conducted in vivo in clinically relevant animal models in a setting that is the closest to human brain tumors, our findings provided strong preclinical evidence to suggest that new stratigies are needed to inhibit these radiation triggered-pathways to improved therapeutic efficacy in pediatric GBM patient. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 570. doi:10.1158/1538-7445.AM2011-570

Abstract 570: Radiation Resistance of Orthotopic Glioblastoma Xenografts is Mediated by Increasing CD133+ Cell Fraction, Mobilizing G0 Cells into G1 Phase, and Activating Self-Renewal and Mesenchymal Genes